HIV-1 genital shedding in HIV-infected patients randomized to second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir

Bunupuradah Torsak; Bowonwattanuwong Chureeratana; Jirajariyavej Supunnee; Munsakul Warangkana; Klinbuayaem Virat; Sophonphan Jiratchaya; Mahanontharit Apicha; Hirschel Bernard; Ruxrungtham Kiat; Ananworanich Jintanat

首页> 外文期刊>Antiviral therapy >HIV-1 genital shedding in HIV-infected patients randomized to second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir

【24h】

HIV-1 genital shedding in HIV-infected patients randomized to second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir

机译：HIV感染患者的HIV-1生殖器脱落随机分为二线洛匹那韦/利托那韦单药治疗与替诺福韦/拉米夫定/洛匹那韦/利托那韦

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: HIV-1 shedding in genital secretions is associated with HIV transmission risk. Limited data exist on the effect of second-line lopinavir/ritonavir monotherapy (mLPV/r) on genital secretion of HIV RNA.

机译：背景：生殖器官分泌物中的HIV-1脱落与HIV传播风险有关。关于二线洛匹那韦/利托那韦单药治疗（mLPV / r）对HIV RNA生殖器分泌的影响的数据有限。

著录项

来源
《Antiviral therapy》 |2014年第6期|共8页
作者
Bunupuradah Torsak; Bowonwattanuwong Chureeratana; Jirajariyavej Supunnee; Munsakul Warangkana; Klinbuayaem Virat; Sophonphan Jiratchaya; Mahanontharit Apicha; Hirschel Bernard; Ruxrungtham Kiat; Ananworanich Jintanat;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. HIV-1 genital shedding in HIV-infected patients randomized to second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir [J] . Bunupuradah Torsak, Bowonwattanuwong Chureeratana, Jirajariyavej Supunnee, Antiviral therapy . 2014,第6期

机译：HIV感染患者的HIV-1生殖器脱落随机分为二线洛匹那韦/利托那韦单药治疗与替诺福韦/拉米夫定/洛匹那韦/利托那韦
2. Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial [J] . Arribas Jose R., Girard Pierre-Marie, Landman Roland, The Lancet infectious diseases . 2015,第7期

机译：洛匹那韦-利托那韦加拉米夫定的双重治疗与洛匹那韦-利托那韦加拉米夫定或恩曲他滨和第二个核苷酸（t）逆转录酶抑制剂用于维持HIV-1病毒抑制（OLE）的三重治疗：随机，开放标签，非自卑审判
3. Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial (vol 15, pg 785, 2015) [J] . Arribas Jose R., Girard Pierre-Marie, Landman Roland The Lancet infectious diseases . 2015,第8期

机译：洛匹那韦-利托那韦加拉米夫定的双重治疗与洛匹那韦-利托那韦加拉米夫定或恩曲他滨和第二个核苷酸（t）逆转录酶抑制剂用于维持HIV-1病毒抑制（OLE）的三重治疗：随机，开放标签，非自卑审判（2015年第15卷，第785页）
4. The Two First-Line Recommended Antiretroviral Regimens for Naive HIV-Infected Patients: Efavirenz-Based Versus Lopinavir-Ritonavir-Based Haart [C] . R. Manfredi, L. Calza, F. Chiodo International AIDS Conference . 2004

机译：幼稚艾滋病毒感染患者的两种第一线推荐的抗逆转录病毒方案：efavirenz为基于Lopinavir-Ritonavir的HAART
5. Cost-Effectiveness Analysis of Nevirapine vs. Ritonavir-Boosted Lopinavir in HIV-infected Children With Peripartum Nevirapine Exposure In Resource-Constrained Areas From Payer's Perspective. [D] . Godwin, Onyeka Peter. 2014

机译：从付款人的角度来看，在资源受限地区感染了围产期尼维拉平的HIV感染儿童中，奈韦拉平vs.利托那韦促进洛匹那韦的成本-效果分析。
6. 2491. Virologic Response of Switching Tenofovir Disoproxil Fumarate (TDF)-Based Regimen to Abacavir (ABC)-Based Regimen vs. Lopinavir/Ritonavir(LPV/r) Plus Lamivudine(3TC) in HIV-Infected Patients with TDF-Induced Nephrotoxicity at 24 Weeks: A Prospective Open-Label Randomized Controlled Trial [O] . Nopporn Songumpai, Opass Putcharoen -1

机译：2491.在24岁时由HIV感染的患者中以替诺福韦双酚富马酸盐（TDF）为基础的方案改用阿巴卡韦（ABC）为基础的方案对洛匹那韦/利托那韦（LPV / r）加拉米夫定（3TC）的病毒学应答周：前瞻性开放标签随机对照对照试验
7. Lopinavir/ritonavir + tenofovir Dual Therapy versus Lopinavir/ritonavir-Based Triple Therapy in HIV-Infected Antiretroviral Naïve Subjects: The Kalead Study [O] . Mari Pinola, Adriano Lazzarin, Andrea Antinori, 2010

机译：Lopinavir / Ritonavir + Tenofovir双重治疗与Lopinavir / Ritonavir的三联疗法在艾滋病毒感染的抗逆转录病毒Naïve主题：Kalead学习

HIV-1 genital shedding in HIV-infected patients randomized to second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir

摘要

著录项

相似文献

相关主题

期刊订阅